Effect of <italic style="font-style: italic">Shugan Jianpi Huoxue Formula</italic> （疏肝健脾活血方） on the CUG Binding Protein 1 Expression and TGF-β1/Smads Signaling Pathway in the Liver Tissue of Liver Fibrosis Model Mice

Yang JIE; Yan HUANG; Zhili WANG; Linmao YE; Junjie ZHANG

doi:10.13288/j.11-2166/r.2022.13.015

您当前的位置：

首页 >

文章列表页 >

Effect of Shugan Jianpi Huoxue Formula （疏肝健脾活血方） on the CUG Binding Protein 1 Expression and TGF-β1/Smads Signaling Pathway in the Liver Tissue of Liver Fibrosis Model Mice

更新时间：2022-06-24

- Effect of Shugan Jianpi Huoxue Formula （疏肝健脾活血方） on the CUG Binding Protein 1 Expression and TGF-β1/Smads Signaling Pathway in the Liver Tissue of Liver Fibrosis Model Mice
- Journal of Traditional Chinese Medicine Vol. 63, Issue 13, Pages: 1276-1282(2022)
- 作者机构：
  
  浙江中医药大学，浙江省杭州市滨江区滨文路548号，310053
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2022.13.015
  CLC：
- Received：27 December 2021，
  
  Revised：2022-03-23，
  
  Published：02 July 2022
- 稿件说明：
移动端阅览
揭阳,黄棪,王志丽等.疏肝健脾活血方对肝纤维化模型小鼠肝组织CUG结合蛋白1表达及TGF-β1/Smads信号通路的影响[J].中医杂志,2022,63(13):1276-1282.

JIE Yang,HUANG Yan,WANG Zhili,et al.Effect of Shugan Jianpi Huoxue Formula （疏肝健脾活血方） on the CUG Binding Protein 1 Expression and TGF-β1/Smads Signaling Pathway in the Liver Tissue of Liver Fibrosis Model Mice[J].Journal of Traditional Chinese Medicine,2022,63(13):1276-1282.
揭阳,黄棪,王志丽等.疏肝健脾活血方对肝纤维化模型小鼠肝组织CUG结合蛋白1表达及TGF-β1/Smads信号通路的影响[J].中医杂志,2022,63(13):1276-1282. DOI： 10.13288/j.11-2166/r.2022.13.015.

JIE Yang,HUANG Yan,WANG Zhili,et al.Effect of Shugan Jianpi Huoxue Formula （疏肝健脾活血方） on the CUG Binding Protein 1 Expression and TGF-β1/Smads Signaling Pathway in the Liver Tissue of Liver Fibrosis Model Mice[J].Journal of Traditional Chinese Medicine,2022,63(13):1276-1282. DOI： 10.13288/j.11-2166/r.2022.13.015.

摘要

目的

探讨疏肝健脾活血方防治肝纤维化的可能作用机制。

方法

48只C57BL/6雄性小鼠随机分为正常组、模型组、疏肝健脾活血方组、CUGBP1敲减组，每组12只。CUGBP1敲减组一次性尾静脉注射CUGBP1敲减腺相关病毒，其余各组尾静脉注射对照腺相关病毒，每只小鼠注射量为100 μl，病毒滴度不少于1×10

vg/ml。4周后，除正常组外，其余各组小鼠腹腔注射20%四氯化碳（CCl

）2.5 ml/kg，每3天注射1次，连续4周，诱导肝纤维化模型；同时疏肝健脾活血方组小鼠予33.3 g/（kg·d）疏肝健脾活血方药液灌胃，正常组、模型组及CUGBP1敲减组予10 ml/kg蒸馏水灌胃，每天1次，连续4周。末次给药12 h后取材，采用HE染色、Masson染色、天狼星红染色进行肝脏病理学观察；检测血清中丙氨酸氨基转移酶（ALT）、门冬氨酸氨基转移酶（AST）水平及肝组织中羟脯氨酸（HYP）含量；检测肝组织中I型胶原（CollagenⅠ）、α平滑肌激动蛋白（α-SMA）、磷酸化Smad2（p-Smad2）、磷酸化Smad3（p-Smad3）、Smad7、CUG结合蛋白1（CUGBP1）蛋白表达，肝组织中转化生长因子β1（TGF-β1）、CollagenⅠ、α-SMA、Smad7、CUGBP1 mRNA表达。

结果

与正常组比较，模型组小鼠肝组织病理显示肝细胞排列紊乱，有大量炎性细胞浸润与大量胶原纤维沉积，并且形成明显的纤维间隔；血清中ALT、AST水平及肝组织中HYP含量上升，肝组织中CollagenⅠ、CUGBP1、p-Smad2、p-Smad3、α-SMA蛋白表达升高，TGF-β1、CollagenⅠ、CUGBP1、α-SMA mRNA表达升高，Smad7蛋白及mRNA表达下降（

＜0.05或

＜0.01）。与模型组比较，疏肝健脾活血方组和CUGBP1敲减组小鼠肝组织病理显示有少量炎性细胞浸润，纤维组织增生不明显，纤维间隔稀疏；血清中ALT、AST水平及肝组织中HYP含量下降，上述蛋白及mRNA水平均有所改善（

＜0.05或

＜0.01）。与疏肝健脾活血方组比较，除Smad7 mRNA表达升高外，CUGBP1敲减组其余各指标差异均无统计学意义（

＞0.05）。

结论

疏肝健脾活血方可能通过抑制肝组织CUGBP1表达，从而阻断TGF-β1/Smads信号后续转导，进而抑制肝纤维化进展。

Abstract

Objective

To explore the possible mechanism of

Shugan Jianpi Huoxue Formula

（疏肝健脾活血方， SJHF） in preventing and treating hepatic fibrosis.

Methods

Forty-eight C57BL/6 male mice were randomly divided into normal group， model group， SJHF group and CUG binding protein 1 （CUGBP1） knockout group， with 12 mice in each group. CUGBP1 knockout group was injected with CUGBP1 knockout adeno-associated virus （AAV9-shRNA-CUGBP1）， while the other three groups were injected with control adeno-associated virus （AAV9-control） through tail vein in volume of 100 μl with viral titers greater than 1×10

vg/ml. Four weeks later， except for the normal group， mice were injected with 2.5 ml/kg of 20% carbon tetrachloride （CCl

） intraperitoneally， once every three days for four weeks to induce hepatic fibrosis model； simultaneously， the SJHF group was given 33.3 g/（kg·d） of SJHF liquid by gavage， while the other three groups were given 100 ml/kg of distilled water by gavage， once a day for four weeks. Materials were collected 12 hours after the last medication，and the pathological morphology of the liver tissue was observed through HE staining， Masson staining and Sirius red staining. The levels of alanine aminotransferase （ALT） and aspartate aminotransferase （AST） in serum， and the hydroxyproline （HYP） content in the liver tissue were detected. The protein expression of type I collagen （CollagenⅠ）， α-smooth muscle actin （α-SMA）， phosphorylated Smad2 （p-Smad2）， phosphorylated Smad3 （p-Smad3）， Smad7， CUG binding protein 1 （CUGBP1）， as well as the mRNA expression of transforming growth factor β1 （TGF-β1）， Collagen Ⅰ， α-SMA， Smad7， and CUGBP1 in the liver tissue were detected.

Results

Compared to those in the normal group， the pathology of the liver tissue in the model group was characterized by disordered arrangement of hepatocytes， a large amount of infiltrated inflammatory cells and deposited collagen fibers， and obvious fibrous septa； the levels of ALT and AST in serum and the content of HYP in liver tissue increased； the CollagenⅠ， CUGBP1， p-Smad2， p-Smad3， and α-SMA protein expressions， as well as TGF-β1， CollagenⅠ， CUGBP1， and α-SMA mRNA expressions increased， while Smad7 protein and mRNA expressions decreased （

＜0.05 or

＜0.01）. Compared to those in the model group， he liver pathology in the SJHF group and the CUGBP1 knockout group showed a small amount of inflammatory cell infiltration， no obvious proliferation of fibrous tissue， and sparse fibrous septa； the levels of ALT and AST in serum， as well as the content of HYP in liver tissue decreased significantly， while all measured protein and mRNA expressions were improved （

＜0.05 or

＜0.01）. Compared to the SJHF group， the CUGBP1 knockout group had higher Smad7 mRNA expression， but no significant differences in other outcomes were found between the groups （

＞0.05）.

Conclusion

SJHF may inhibit the progression of hepatic fibrosis by inhibiting the expression of CUGBP1 in the liver tissue and blocking the subsequent transduction of TGF-β1/Smads signal.

关键词

Keywords

references

单姗，赵连晖，马红，等 . 肝硬化的定义、病因及流行病学［J］. 临床肝胆病杂志， 2021 ， 37 （ 1 ）： 14 - 16 .

KISSELEVA T ， BRENNER D . Molecular and cellular mechanisms of liver fibrosis and its regression ［J］. Nat Rev Gastroenterol Hepatol ， 2021 ， 18 （ 3 ）： 151 - 166 .

HIGASHI T ， FRIEDMAN SL ， HOSHIDA Y . Hepatic stellate cells as key target in liver fibrosis ［J］. Adv Drug Deliv Rev ， 2017 ， 121 ： 27 - 42 . doi： 10.1016/j.addr. 2017.05.007 http://dx.doi.org/10.1016/j.addr.2017.05.007 .

FRANZINI M ， FORNACIARI I ， SICILIANO G ， et al . Serum gamma-glutamyltransferase fractions in myotonic dystrophy type I： differences with healthy subjects and patients with liver disease ［J］. Clin Biochem ， 2010 ， 43 （ 15 ）： 1246 - 1248 .

WU X ， WU X ， MA Y ， et al . CUG-binding protein 1 regulates HSC activation and liver fibrogenesis ［J］. Nat Commun ， 2016 ， 7 ： 13498 . doi： 10.1038/ncomms13498 http://dx.doi.org/10.1038/ncomms13498 .

周凝，杨欣，夏雪皎，等 . 疏肝健脾活血方对大鼠肝星状细胞TGF-β1/Smads信号通路的影响［J］. 浙江中西医结合杂志， 2018 ， 28 （ 4 ）： 267 - 270 .

黄继汉，黄晓晖，陈志扬，等 . 药理试验中动物间和动物与人体间的等效剂量换算［J］. 中国临床药理学与治疗学， 2004 ， 9 （ 9 ）： 1069 - 1072 .

陈刚，李宏波，邱少敏． CCl 4 皮下注射制备大鼠肝纤维化模型的研究［J］. 现代医学， 2010 ， 38 （ 3 ）： 225 - 229 ．

SCHOLTEN D ， TREBICKA J ， LIEDTKE C ， et al . The carbon tetrachloride model in mice ［J］. Lab Anim ， 2015 ， 49 （ 1 suppl ）： 4 - 11 .

刘雪冰，李幸，吴玉潇，等 . 中医从“瘀”与“虚”论治肝纤维化的研究进展［J］. 中医临床研究， 2020 ， 12 （ 22 ）： 137 - 142 .

骆欢欢，王新华 . 从肝瘀正虚论肝纤维化治疗思路［J］. 中医杂志， 2010 ， 51 （ 5 ）： 463 - 465 .

DEWIDAR B ， MEYER C ， DOOLEY S ， et al . TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019 ［J］. Cells ， 2019 ， 8 （ 11 ）： 1419 .

XU F ， LIU C ， ZHOU D ， et al . TGF-β/SMAD pathway and its regulation in hepatic fibrosis ［J］. J Histochem Cytochem ， 2016 ， 64 （ 3 ）： 157 - 167 .

KAMATO D ， BURCH ML ， PIVA TJ ， et al . Transforming growth factor-β signalling： role and consequences of Smad linker region phosphorylation ［J］. Cell Signall ， 2013 ， 25 （ 10 ）： 2017 - 2024 .

VLASOVA-ST LI ， BOHJANEN PR . Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1 ［J］. Curr Opin Genet Dev ， 2011 ， 21 （ 4 ）： 444 - 451 .

JONES K ， TIMCHENKO L ， TIMCHENKO NA . The role of CUGBP1 in age-dependent changes of liver functions ［J］. Ageing Res Rev ， 2012 ， 11 （ 4 ）： 442 - 449 .

LEWIS K ， VALANEJAD L ， CAST A ， et al . RNA binding protein CUGBP1 inhibits liver cancer in a phosphorylation-dependent manner ［J］. Mol Cell Biol ， 2017 ， 37 （ 16 ）： e00128-17 . doi： 10.1128/MCB. 00128-17 http://dx.doi.org/10.1128/MCB.00128-17 .

PAROLA M ， PINZANI M . Liver fibrosis： pathophysiology， pathogenetic targets and clinical issues ［J］. Mol Aspect Med ， 2019 ， 65 ： 37 - 55 . doi： 10.1016/j.mam. 2018. 09.002 http://dx.doi.org/10.1016/j.mam.2018.09.002 .

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Immune-Metabolic Reprogramming in Hepatic Fibrosis and Its Micro-Level Syndrome Differentiation and Treatment：from the Perspective of "Liver Being the General and Spleen Being the Defender"

Effect of Fugan Huaxian Decoction （扶肝化纤汤） on Th17/Treg Balance and Related Transcription Factors in Hepatic Fibrosis with Healthy Qi Deficiency and Toxin Accumulation Pattern Model Rats

Effects of Yinqi Sanhuang Jiedu Decoction （茵芪三黄解毒汤） on Liver Hardness and Epithelial Mesenchymal Transition in Hepatic Fibrosis Model Mice

Effect of Qiwei Granules on TGF-β1/Smads Signaling Pathway in Renal Tissue in KK-Ay Mice

Effect of Notoginseng Total Glucoside on the Dimethylnitrosamine Induced Hepatic Fibrosis of Rat Models

Related Author

LYU Wenliang

SHEN Yaocun

WANG Yi

OUYANG Jiqi

XIAO Zhenghua

LU Luxing

LI Qing

CUI Junsong

Related Institution

Guang 'anmen Hospital，China Academy of Chinese Medical Sciences

Graduate School，Beijing University of Chinese Medicine

Guizhou University of Traditional Chinese Medicine

The Second Affliated Hospital of Guizhou University of Traditional Chinese Medicine

TCM of School, Capital Medical University

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Effect of Shugan Jianpi Huoxue Formula （疏肝健脾活血方） on the CUG Binding Protein 1 Expression and TGF-β1/Smads Signaling Pathway in the Liver Tissue of Liver Fibrosis Model Mice

DOI：10.13288/j.11-2166/r.2022.13.015

摘要

Abstract

关键词

Keywords

references